BioNTech SE Acquisitiondate Fair Value Of Total Consideration Transferred
BioNTech SE (BNTX) had Acquisitiondate Fair Value Of Total Consideration Transferred of $1.00 billion as of 2022-12-31, per its 20-F filed 2023-03-27.
Discontinued › Notes
ifrs-full:AcquisitiondateFairValueOfTotalConsiderationTransferred · last filed 2023-03-27
- 2022-12-31: Acquisitiondate Fair Value Of Total Consideration Transferred $1.00B.
| Period end | Acquisitiondate Fair Value Of Total Consideration Transferred |
|---|---|
| 2022-12-31 | $1.00B 20-F · filed 2023-03-27 |